BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18344087)

  • 21. Cyclin E and survival in patients with breast cancer.
    Keyomarsi K; Tucker SL; Buchholz TA; Callister M; Ding Y; Hortobagyi GN; Bedrosian I; Knickerbocker C; Toyofuku W; Lowe M; Herliczek TW; Bacus SS
    N Engl J Med; 2002 Nov; 347(20):1566-75. PubMed ID: 12432043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma.
    Sakuragi N; Takeda N; Hareyama H; Fujimoto T; Todo Y; Okamoto K; Takeda M; Wada Si; Yamamoto R; Fujimoto S
    Cancer; 2000 Jun; 88(11):2578-83. PubMed ID: 10861436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.
    Berglund P; Stighall M; Jirström K; Rydén L; Fernö M; Nordenskjöld B; Landberg G
    J Clin Pathol; 2008 Feb; 61(2):184-91. PubMed ID: 17483245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
    Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer.
    Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
    Cancer Res; 2000 Jan; 60(2):242-4. PubMed ID: 10667567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depth of mesorectal invasion has prognostic significance in T3N0 low rectal cancer.
    Tokoro T; Okuno K; Hida J; Ishimaru E; Ueda K; Yoshifuji T
    Hepatogastroenterology; 2009; 56(89):124-7. PubMed ID: 19453042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M
    J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D; Nielsen TO; Cheang MC; Foulkes WD
    Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer].
    Gao YS; Xing XZ; Shao K; Feng XL; He J
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):134-7. PubMed ID: 18646698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis.
    Liang P; Nakada I; Hong JW; Tabuchi T; Motohashi G; Takemura A; Nakachi T; Kasuga T; Tabuchi T
    Ann Surg Oncol; 2007 Feb; 14(2):470-7. PubMed ID: 17103258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer.
    Kato T; Kimura T; Miyakawa R; Fujii A; Yamamoto K; Kameoka S; Nishikawa T; Kasajima T
    Br J Cancer; 2000 Jan; 82(2):404-11. PubMed ID: 10646896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
    Huh JW; Kim HR; Kim YJ
    Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
    Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
    Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
    Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic role of apoptosis mediators in rectal adenocarcinoma.
    Seicean R; Crisan D; Boers JE; Mocan T; Seicean A; Funariu G; Ciuce C
    Hepatogastroenterology; 2011; 58(110-111):1490-4. PubMed ID: 21940317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.